Insider · CIK 0001515322
Andy Sassine
Files at ICAD (ICAD INC), ARCT (Arcturus Therapeutics Holdings Inc.). First filing Aug 19, 2025, latest Aug 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARCT: Arcturus Therapeutics Holdings Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | ARCTbuy Arcturus Therapeutics Holdings Inc. | $20k 1,238 shares | +1% | +119% from low-24% from high | |
| 21Weak | ARCTbuy Arcturus Therapeutics Holdings Inc. | $20k 1,238 shares | +1% | +119% from low-24% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 15, 2025 | ARCT Arcturus Therapeutics Holdings Inc. | POpen-market purchase Common Stock | +1,238 | $16.56 | $20k | 221,764 | Aug 20, 2025 |
| Aug 15, 2025 | ARCT Arcturus Therapeutics Holdings Inc. | POpen-market purchase Common Stock | -1,238 | $16.56 | $20k | 221,764 | Aug 19, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Common Stock | -1,198,382 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -6,219 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -6,517 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -9,321 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -20,000 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -4,002 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -2,672 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -28,774 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -12,954 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -34,706 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,265 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -22,259 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -27,586 | - | - | 0 | Jul 17, 2025 |
| Jul 17, 2025 | ICAD ICAD INC | DDisposition to issuer Stock Option (right to buy)derivative | -30,000 | - | - | 0 | Jul 17, 2025 |
| Jan 3, 2025 | ICAD ICAD INC | AGrant or award Director Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jan 7, 2025 |
| Dec 16, 2024 | ARCT Arcturus Therapeutics Holdings Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.